Skip to main content
. 2022 Mar 3;10(3):385. doi: 10.3390/vaccines10030385

Figure 1.

Figure 1

(A) Showing differences in anti-SARS-CoV-2 antibody titer between three groups; (B) anti-SARS-CoV-2 antibody titer between Covaxin and Covishield.